Miss Rachel Lackey, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2515 Junior College Blvd, Wharton, TX 77488 Phone: 832-392-4835 |
Mrs. Andrea Elease Myers-griffin, Registered Nurse - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 6818 W Fm 1161 Rd, Wharton, TX 77488 Phone: 979-533-4538 |
Sara Katheryn Tyler, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 415 Philip St, Wharton, TX 77488 Phone: 979-323-4320 |
Stacey Silvas, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1405 Valhalla Dr, Wharton, TX 77488 Phone: 979-532-1244 |
News Archive
Since World War II, medical ethics in research studies involving human subjects have shifted significantly. Despite this important growth, ethical issues remain. Nutrition supplementation research does not have guidelines around the use of placebo groups in clinical trials, posing ethical issues.
MEDICREA announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market the PASS LP Iliac Fixation within the United States. This new Iliac Fixation supplements the PASS LP range, a ultra Low Profile Polyaxial Spine System launched recently.
In recent years, children's hospitals have joined in the national push to improve patient safety and avoid preventable problems. But it has been hard to measure progress, because of uncertainty about whether standard patient safety measurement tools apply to their patients, who are younger, smaller and on average sicker than those at other hospitals.
Rick Santorum snapped his four-state losing streak Tuesday with wins in three GOP presidential caucuses. Meanwhile, the GOP candidates are hitting front-runner Mitt Romney on the similarity of a rule he presided over in Massachusetts that required even Catholic hospitals to provide the morning-after pill - comparing it to a recent Obama administration controversy on contraception.
BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly adjusted revenues of $3.067 billion for the fourth fiscal quarter ended September 30, 2015, an increase of 39.3 percent over the prior-year period as reported, or 49.1 percent on a currency-neutral basis.
› Verified 8 days ago